Director, CEO · Estrella Immunopharma, Inc. · Estrella Immunopharma, Inc. — Incentive Stock Option
Side
M
Value
—
Shares
100.0K
Price
—
Executed
Aug 25, 2026
Disclosed
Aug 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 25 executedAug 26, 2026 disclosed
ESLA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 12.5% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Estrella Immunopharma, Inc. — Incentive Stock Option
Ticker
ESLA
Shares
100.0K
Price per share
$0
Execution date (reported)
Aug 25, 2026
Owned after transaction
900.0K shares
Days from execution to publication
1
What this establishes
Liu Cheng filed this Form 4 reporting a option exercise of ESLA on Aug 25, 2026. It became public on Aug 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO
Liu Chengcik:0001996255
Issuer
Estrella Immunopharma, Inc.cik:0001844417
Revision history · 0
No field has changed since this record was first ingested.
